AB0494 Filgotinib (GLPG0634), a Selective JAK1 Inhibitor, Shows Similar PK and PD Profiles in Japanese and Caucasian Healthy Volunteers
Namour, F., Vayssière, B., Galien, R., Fagard, L., Van der Aa, A., Harrison, P., Tasset, C.
Published in Annals of the rheumatic diseases (01.06.2015)
Published in Annals of the rheumatic diseases (01.06.2015)
Get full text
Journal Article
ADAMTS-5 inhibitor GLPG1972, a potential new treatment in osteoarthritis, shows favorable safety, pharmacokinetics and pharmacodynamics in healthy subjects
van der Aar, E.M., Desrivot, J., Fagard, L., Amantini, D., Larsson, S., Struglics, A., Lohmander, S., Vanhoutte, F., Dupont, S.
Published in Osteoarthritis and cartilage (01.04.2018)
Published in Osteoarthritis and cartilage (01.04.2018)
Get full text
Journal Article
A103 IPF: MORE ABOUT THERAPY AND OUTCOMES: Favorable Human Safety, Pharmacokinetics And Pharmacodynamics Of The Autotaxin Inhibitor Glpg1690, A Potential New Treatment In Idiopathic Pulmonary Fibrosis
Van Der Aar, E M, Fagard, L, Desrivot, J, Dupont, S, Heckmann, B, Blanque, R, Gheyle, L, Ralic, J, Vanhoutte, F
Published in American journal of respiratory and critical care medicine (01.01.2016)
Get full text
Published in American journal of respiratory and critical care medicine (01.01.2016)
Journal Article